Potassium channels sensitive to combination of charybdotoxin and apamin regulate the tone of diabetic isolated canine coronary arteries

Acta Physiol (Oxf). 2008 Sep;194(1):35-43. doi: 10.1111/j.1748-1716.2008.01859.x. Epub 2008 Apr 3.

Abstract

Aims: Functional roles of calcium-activated potassium channels on the mechanical activity of epicardial coronary arteries obtained from a canine model of diabetes were investigated.

Methods: Coronary arteries were isolated from healthy, alloxan-diabetic and insulin-treated diabetic dogs. Basal tensions, contractions induced by the prostaglandin (PG) analogue, U46619, and endothelium-dependent relaxations to acetylcholine (ACh) were modified with charybdotoxin (CHTX) + apamin (APA), inhibitors of calcium-activated potassium channels, as well as with N(omega)-nitro-l-arginine (LNA) + indomethacin (INDO) to suppress the synthesis of nitric oxide (NO) and PGs. The relaxing effect of nitroprusside-sodium (SNP), an NO donor, was also determined.

Results: In diabetic coronary arteries, CHTX + APA did not change while LNA + INDO elevated the basal tension. PG-induced contractions were enhanced by CHTX + APA and by LNA + INDO in all the three groups of animals. CHTX + APA decreased the maximal relaxations to ACh in a partly insulin-dependent manner. LNA + INDO abolished the endothelium-dependent relaxations to ACh. In diabetic coronary arteries, the sensitivity to SNP-induced relaxation was enhanced, insulin independently, suggesting that NO could be partly responsible for maintaining intact ACh-induced vasorelaxation.

Conclusion: In diabetic canine coronary artery, the vasomotor responses reflect up-regulation of calcium-activated potassium channels. This endothelial mechanism of the canine epicardial coronary artery may oppose vasoconstrictions in diabetic vascular tissue.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Acetylcholine / pharmacology
  • Animals
  • Apamin / pharmacology*
  • Charybdotoxin / pharmacology*
  • Coronary Vessels / drug effects*
  • Diabetes Mellitus, Experimental / physiopathology*
  • Dogs
  • Endothelium, Vascular / drug effects
  • Female
  • In Vitro Techniques
  • Insulin / pharmacology
  • Isometric Contraction / drug effects
  • Male
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels / physiology*
  • S-Nitroso-N-Acetylpenicillamine / pharmacology
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology

Substances

  • Insulin
  • Potassium Channel Blockers
  • Potassium Channels
  • Vasoconstrictor Agents
  • Charybdotoxin
  • Apamin
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • S-Nitroso-N-Acetylpenicillamine
  • Acetylcholine